The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Antibiotic Resistance Among Uropathogenic Escherichia coli
Open accessAbstract
Urinary tract infections (UTIs) belong to the most common community-acquired and nosocomial infections. A main etiological factor of UTIs is uropathogenic Escherichia coli (UPEC). This review describes the current state of knowledge on the resistance of UPEC to antibiotics recommended for the treatment of UTIs based on the available literature data. Nitrofurantoin and fosfomycin are recommended as first-line therapy in the treatment of uncomplicated cystitis, and the resistance to these antimicrobial agents remains low between UPEC. Recently, in many countries, the increasing resistance is observed to trimethoprim-sulfamethoxazole, which is widely used as the first-line antimicrobial in the treatment of uncomplicated UTIs. In European countries, the resistance of UPEC to this antimicrobial agent ranges from 14.6% to 60%. The widespread use of fluoroquinolones (FQs), especially ciprofloxacin, in the outpatients is the cause of a continuous increase in resistance to these drugs. The resistance of UPEC to FQs is significantly higher in developing countries (55.5–85.5%) than in developed countries (5.1–32.0%). Amoxicillin-clavulanic acid is recommended as first line-therapy for pyelonephritis or complicated UTI. Resistance rates of UPEC to amoxicillin-clavulanic acid are regionally variable. In European countries the level of resistance to this antimicrobial ranges from 5.3% (Germany) to 37.6% (France). Increasing rates of UPEC resistance to antimicrobials indicate that careful monitoring of their use for UTI treatment is necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Palombo, C., Morizzo, C., Baluci, M., Lucini, D., Ricci, S., Biolo, G., Tortoli, P., & Kozakova, M. (2015) · BioMed Research International · doi:10.1155/2015/342565 · Cited by 750
Sarowska, J., Futoma-Koloch, B., Jama-Kmiecik, A., Frej-Madrzak, M., Ksiazczyk, M., Bugla-Ploskonska, G., & Choroszy-Krol, I. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0290-0 · Cited by 718
Terlizzi, M. E., Gribaudo, G., & Maffei, M. E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01566 · Cited by 692
Global dissemination of a multidrug resistant Escherichia coli clone
Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M.-D., Gomes Moriel, D., Peters, K. M., Davies, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322678111 · Cited by 558
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Riley, L. W. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12646 · Cited by 412
Urinary Tract Infection: Pathogenesis and Outlook
McLellan, L. K., & Hunstad, D. A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.003 · Cited by 382
Komp Lindgren, P., Karlsson, A., & Hughes, D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3222-3232.2003 · Cited by 350
Naber, K. G., Schito, G., Botto, H., Palou, J., & Mazzei, T. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.010 · Cited by 316
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Banerjee, R., & Johnson, J. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02824-14 · Cited by 268
Kallonen, T., Brodrick, H. J., Harris, S. R., Corander, J., Brown, N. M., Martin, V., Peacock, S. J., & Parkhill, J. (2017) · Genome Research · doi:10.1101/gr.216606.116 · Cited by 259
Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing
Tartof, S. Y., Solberg, O. D., Manges, A. R., & Riley, L. W. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5860-5864.2005 · Cited by 248
Asadi Karam, M. R., Habibi, M., & Bouzari, S. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.02.007 · Cited by 219
Ramírez-Castillo, F. Y., Moreno-Flores, A. C., Avelar-González, F. J., Márquez-Díaz, F., Harel, J., & Guerrero-Barrera, A. L. (2018) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-018-0286-5 · Cited by 218
Fasugba, O., Gardner, A., Mitchell, B. G., & Mnatzaganian, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1282-4 · Cited by 216
Fosfomycin: Pharmacological, Clinical and Future Perspectives
Dijkmans, A. C., Zacarías, N. V. O., Burggraaf, J., Mouton, J. W., Wilms, E., Van Nieuwkoop, C., Touw, D. J., Stevens, J., & Kamerling, I. M. C. (2017) · Antibiotics · doi:10.3390/antibiotics6040024 · Cited by 198
Fosfomycin: an old, new friend?
Popovic, M., Steinort, D., Pillai, S., & Joukhadar, C. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0833-2 · Cited by 197
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
Sandegren, L., Lindqvist, A., Kahlmeter, G., & Andersson, D. I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn222 · Cited by 196
Kim, D. H., Lees, W. J., Kempsell, K. E., Lane, W. S., Duncan, K., & Walsh, C. T. (1996) · Biochemistry · doi:10.1021/bi952937w · Cited by 192
Neuner, E. A., Sekeres, J., Hall, G. S., & van Duin, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-12 · Cited by 189
Sanchez, G. V., Babiker, A., Master, R. N., Luu, T., Mathur, A., & Bordon, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02897-15 · Cited by 177
Gibreel, T. M., Dodgson, A. R., Cheesbrough, J., Fox, A. J., Bolton, F. J., & Upton, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr451 · Cited by 173
Filippini, M., Masiero, G., & Moschetti, K. (2006) · Health Policy · doi:10.1016/j.healthpol.2005.09.009 · Cited by 172
Parajuli, N. P., Maharjan, P., Parajuli, H., Joshi, G., Paudel, D., Sayami, S., & Khanal, P. R. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-016-0168-6 · Cited by 159
Tenney, J. W., Hudson, N., Alnifaidy, H., Li, J. T. C., & Fung, K. H. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.02.023 · Cited by 159
Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract
Mann, R., Mediati, D. G., Duggin, I. G., Harry, E. J., & Bottomley, A. L. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00241 · Cited by 158
Lob, S. H., Nicolle, L. E., Hoban, D. J., Kazmierczak, K. M., Badal, R. E., & Sahm, D. F. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.04.022 · Cited by 146
Jakobsen, L., Spangholm, D. J., Pedersen, K., Jensen, L., Emborg, H., Agersø, Y., Aarestrup, F. M., Hammerum, A. M., & Møller, J. K. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.06.025 · Cited by 143
Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness
Nordstrom, L., Liu, C. M., & Price, L. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00029 · Cited by 142
Cranberry and Recurrent Cystitis: More than Marketing?
Micali, S., Isgrò, G., Bianchi, G. P., Miceli, N., Calapai, G., & Navarra, M. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.625574 · Cited by 139
Urinary Tract Infection in Male Veterans
Drekonja, D. M., Rector, T. S., Cutting, A. H., & Johnson, J. R. (2012) · JAMA Internal Medicine · doi:10.1001/2013.jamainternmed.829 · Cited by 132
Walker, E., Lyman, A., Gupta, K., Mahoney, M. V. G., Snyder, G. M., & Hirsch, E. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw396 · Cited by 130
Brumbaugh, A. R., Smith, S. N., & Mobley, H. L. T. (2013) · Infection and Immunity · doi:10.1128/iai.00470-13 · Cited by 126
Talan, D. A., Takhar, S. S., Krishnadasan, A., Abrahamian, F. M., Mower, W. R., Moran, G. J., & EMERGEncy ID Net Study Group (2016) · Emerging infectious diseases · doi:10.3201/eid2209.160148 · Cited by 126
Adams, S. M., Diep, B. A., Perdreau‐Remington, F., & Riley, L. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01025-12 · Cited by 122
Blood Cultures for Women with Uncomplicated Acute Pyelonephritis: Are They Necessary?
Velasco, M., Martínez, J. A., Moreno-Martínez, A., Horcajada, J. P., Ruiz, J., Barranco, M., Almela, M., Vilà, J., & Mensa, J. (2003) · Clinical Infectious Diseases · doi:10.1086/378291 · Cited by 119
Noyal, M. J. C., Menezes, G. A., Harish, B. N., Sujatha, S., & Parija, S. (2009) · PubMed · Cited by 114
Abernethy, J., Guy, R. L., Sheridan, E. A. S., Hopkins, S., Kiernan, M., Wilcox, M. H., Johnson, A. P., Hope, R., Sen, R. A., Mifsud, A., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.12.008 · Cited by 109
Bischoff, S., Walter, T., Gerigk, M., Ebert, M. P. A., & Vogelmann, R. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-2960-9 · Cited by 109
Wagenlehner, F., Tandoğdu, Z., Bartoletti, R., Cai, T., Çek, M., Kulchavenya, E., Köves, B., Naber, K. G., Perepanova, T. S., Peter Tenke, A., et al. (2016) · Pathogens · doi:10.3390/pathogens5010010 · Cited by 104
Tchesnokova, V. L., Rechkina, E., Larson, L., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy525 · Cited by 104
Paniagua-Contreras, G., Monroy-Pérez, E., Rodríguez-Moctezuma, J. R., Domínguez-Trejo, P., Vaca-Paniagua, F., & Vaca, S. (2017) · Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · doi:10.1016/j.jmii.2015.08.005 · Cited by 94
Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan
Ali, I., Rafaque, Z., Ahmed, S., Malik, S., & Dasti, J. I. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2015.09.022 · Cited by 93
Improved Classification of Urinary Tract Infection: Future Considerations
Smelov, V., Naber, K. G., & Johansen, T. E. B. (2016) · European Urology Supplements · doi:10.1016/j.eursup.2016.04.002 · Cited by 92
Yandag, M., Gunregjav, N., Altantsetseg, D., Juniichiro, N., & Jav, S. (2017) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7903 · Cited by 87
Yamaji, R., Rubin, J., Thys, E., Friedman, C. R., & Riley, L. W. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01834-17 · Cited by 82
High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran
Faghri, J., Dehbanipour, R., Rastaghi, S., Sedighi, M., & Maleki, N. (2016) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.175020 · Cited by 81
ANTIBIOTIC RESISTANCE PATTERNS OF URINARY TRACT INFECTIONS IN A NORTHEASTERN BRAZILIAN CAPITAL
Cunha, M. A., Assunção, G. L. M. D., de Medeiros, I. M., & de Freitas, M. R. (2016) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201658002 · Cited by 81
Alghoribi, M. F., Gibreel, T. M., Farnham, G., Johani, S. M. A., Balkhy, H. H., & Upton, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv188 · Cited by 79
Bahagon, Y., Raveh, D., Schlesinger, Y., Rudensky, B., & Yinnon, A. M. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0287-3 · Cited by 75
Schneeberger, C., Kazemier, B. M., & Geerlings, S. E. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000028 · Cited by 73
Hirsch, E. B., Raux, B. R., Zucchi, P., Kim, Y., McCoy, C. P., Kirby, J. E., Wright, S. B., & Eliopoulos, G. M. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.012 · Cited by 70
Mellata, M., Johnson, J. R., & Curtiss, R. (2017) · Zoonoses and Public Health · doi:10.1111/zph.12376 · Cited by 69
Ojdana, D., Sacha, P., Wieczorek, P., Czaban, S. L., Michalska‐Falkowska, A., Jaworowska, J., Jurczak, A., Poniatowski, B., & Tryniszewska, E. A. (2014) · International Journal of Antibiotics · doi:10.1155/2014/935842 · Cited by 66
Tabasi, M. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/21379.9009 · Cited by 65
Blaettler, L., Mertz, D., Frei, R., Elzi, L., Widmer, A. F., Battegay, M., & Flückiger, U. M. (2009) · Infection · doi:10.1007/s15010-009-8457-0 · Cited by 60
Adamus-Białek, W., Baraniak, A., Wawszczak-Kasza, M., Głuszek, S., Gad, B., Wróbel, K., Bator, P., Majchrzak, M., & Parniewski, P. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4254-0 · Cited by 58
Lavigne, J., Bruyère, F., Bernard, L., Combescure, C., Ronco, E., Lanotte, P., Coloby, P. J., Thibault, M., Cariou, G., Desplaces, N., et al. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000247 · Cited by 52
Morrill, H. J., Morton, J. B., Caffrey, A. R., Jiang, L., Dosa, D. M., Mermel, L. A., & LaPlante, K. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02236-16 · Cited by 50
Ghany, M. A. E., Sharaf, H., Al-Agamy, M. H., Shibl, A. M., Hill-Cawthorne, G. A., & Hong, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201613 · Cited by 49
Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario
Laishram, S., & Veeraraghavan, B. (2015) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.167350 · Cited by 47
Baudry, P. J., Nichol, K. A., DeCorby, M. R., Lagacé-Wiens, P. R. S., Olivier, E., Boyd, D. A., Mulvey, M. R., Hoban, D. J., & Zhanel, G. G. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.12.001 · Cited by 46
van der Donk, C. F. M., van de Bovenkamp, J. H. B., de Brauwer, E. I. G. B., Mol, P. D., Feldhoff, K., Kalka-Moll, W. M., Nys, S., Thoelen, I., Trienekens, T. A. M., & Stobberingh, E. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047707 · Cited by 43
Cristea, V. C., Gheorghe, I., Barbu, I. C., Popa, L. I., Ispas, B., Grigore, G. A., Bucatariu, I., Popa, G. L., Angelescu, M.-C., Velican, A. M., et al. (2019) · BioMed Research International · doi:10.1155/2019/5712371 · Cited by 42
Erb, S., Frei, R., Tschudin‐Sutter, S., Egli, A., Dangel, M., Bonkat, G., & Widmer, A. F. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14660 · Cited by 40
van Nieuwkoop, C., Bonten, T. N., Wout, J. W. V., Becker, M. J., Groeneveld, G. H., Jansen, C. L., van der Vorm, E. R., IJzerman, E. P. F., Rothbarth, P. H., TerMeer‐Veringa, E. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652657 · Cited by 34
Antibiotic Resistance in Urinary Isolates of Escherichia coli
Abduzaimović, A., Aljičević, M., Rebić, V., Vranić, S. M., Abduzaimović, K., & Šestić, S. (2016) · Materia Socio Medica · doi:10.5455/msm.2016.28.416-419 · Cited by 33
Therapies in early development for the treatment of urinary tract inflammation
Zacchè, M. M., & Giarenis, I. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1161024 · Cited by 27
Shakhatreh, M. A. K., Swedan, S. F., Al-Odat, M. A., & Khabour, O. F. (2018) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2018.03.009 · Cited by 27
da Silva, R. C. R. M., Martins, P. D. O., Gonçalves, L. F., Martins, V. D. P., de Melo, A. B. F., Pitondo‐Silva, A., & de Campos, T. A. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.01.009 · Cited by 24
Hojabri, Z., Mirmohammadkhani, M., Darabi, N., Arab, M., & Pajand, O. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s199759 · Cited by 20
Habibi, A., & Khameneie, M. K. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i8.21 · Cited by 16
Hof, H. (2016) · Der Urologe · doi:10.1007/s00120-016-0219-x · Cited by 14
Abdelhamid, S. M., & Abozahra, R. (2017) · Polish Journal of Microbiology · doi:10.5604/17331331.1234990 · Cited by 13
Cheung, A., Karmali, G., Noble, S., & Song, H. K. (2017) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v70i2.1648 · Cited by 10
Delpech, G., Allende, N., Lissarrague, S., & Sparo, M. D. (2018) · The Open Infectious Diseases Journal · doi:10.2174/1874279301810010079 · Cited by 6
Cited by
Urinary Tract Infections: The Current Scenario and Future Prospects
Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., & Biondo, C. (2023) · Pathogens · doi:10.3390/pathogens12040623 · Cited by 396
Metadata
- Authors
- KOT, B.
- Venue
- Polish Journal of Microbiology
- Publisher
- Polish Society of Microbiologists
- Published
- 2019-12-01
- Volume
- 68
- Issue
- 4
- Pages
- 403-415
- ISSN
- 1733-1331 (ISSN-L)
- 2544-4646
- OpenAlex
- W2995225293
- Cited by
- 277
- References
- 77
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.